- Home
- CGNT vs ARCT Comparison
CGNT vs ARCT Comparison
Compare CGNT & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGNT
- ARCT
- Stock Information
- Founded
- CGNT 2020
- ARCT 2013
- Country
- CGNT Israel
- ARCT United States
- Employees
- CGNT N/A
- ARCT N/A
- Industry
- CGNT Computer Software: Prepackaged Software
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- CGNT Technology
- ARCT Health Care
- Exchange
- CGNT Nasdaq
- ARCT Nasdaq
- Market Cap
- CGNT 639.4M
- ARCT 487.0M
- IPO Year
- CGNT N/A
- ARCT N/A
- Fundamental
- Price
- CGNT $9.34
- ARCT $17.12
- Analyst Decision
- CGNT Hold
- ARCT Strong Buy
- Analyst Count
- CGNT 3
- ARCT 7
- Target Price
- CGNT $8.25
- ARCT $65.00
- AVG Volume (30 Days)
- CGNT 283.2K
- ARCT 348.5K
- Earning Date
- CGNT 12-11-2024
- ARCT 03-06-2025
- Dividend Yield
- CGNT N/A
- ARCT N/A
- EPS Growth
- CGNT N/A
- ARCT N/A
- EPS
- CGNT N/A
- ARCT N/A
- Revenue
- CGNT $339,818,000.00
- ARCT $160,399,000.00
- Revenue This Year
- CGNT $13.67
- ARCT $7.33
- Revenue Next Year
- CGNT $6.92
- ARCT $4.71
- P/E Ratio
- CGNT N/A
- ARCT N/A
- Revenue Growth
- CGNT 12.16
- ARCT N/A
- 52 Week Low
- CGNT $6.21
- ARCT $14.30
- 52 Week High
- CGNT $9.97
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- CGNT 57.96
- ARCT 48.75
- Support Level
- CGNT $9.12
- ARCT $15.82
- Resistance Level
- CGNT $9.97
- ARCT $17.93
- Average True Range (ATR)
- CGNT 0.34
- ARCT 1.51
- MACD
- CGNT 0.02
- ARCT -0.04
- Stochastic Oscillator
- CGNT 58.00
- ARCT 23.90
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.